More Medical Articles


On the journey from pill to platform

Andrew Stone, (Jun 3, 2021)

For AstraZeneca’s Alex Bedenkov, investing more in post-pandemic medical capabilities is just the start of a far more profound organisation-wide transformation

From insight to action in medical affairs

Nicola Davies, (May 6, 2021)

Physicians’ increasingly digital-first consumption of disease state education offers pharma a way to understand their needs more deeply and so find better ways to serve them

Redefining the role of the MSL in a changed world

Andrew Stone, (Mar 24, 2021)

MSLs will need to respond to the growing demands being placed on them in the new normal by adopting new approaches, capabilities and skill sets
Access and Evidence

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
Access and Evidence

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Izzy Gladstone, (Feb 11, 2021)

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021

COVID-19: A data challenge and a catalyst for new insights

Andrew Stone, (Nov 24, 2020)

The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Access and Evidence

Survey results: Accelerating digital transformation during COVID-19

Nicola Davies, (Sep 4, 2020)

View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations

Paying for cell and gene therapy - Is the future already here?

Ulrich Neumann, (Aug 25, 2020)

Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome

The age of the digital opinion leader

Andrew Stone, (Jul 28, 2020)

Key opinion leaders who evolve into the digital sphere to become digital opinion leaders will gain more reach and influence

The key to digital innovation: The human touch

Andrew Stone, (Jun 30, 2020)

Takeda is building on strong stakeholder relationships it has nurtured patiently over time to co-create solutions during COVID-19